Piper Jaffray Downgrades Corcept Therapeutics (CORT) to Neutral

May 6, 2013 7:27 AM

Piper Jaffray downgraded Corcept Therapeutics (NASDAQ: CORT) from Overweight to Neutral with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found